Paul Anderson

Teaching Strengths

Calcium Metabolism
Bone Health and Disease
Vitamin D Biology
Renal Function and Pathophysiology

APrf Paul Anderson

Associate Professor of Physiology

School of Pharmacy and Biomedical Science

College of Health

Available For Media Comment.

I am an Associate Professor of Physiology at the University of South Australia, where I lead research focused on improving musculoskeletal health and preventing chronic diseases. As the Bone Research Theme Leader, I collaborate with academic, clinical, and industry partners to translate scientific discoveries into practical health solutions.
My research encompasses:

Developing dietary and pharmacological strategies to prevent and treat osteoporosis and osteoarthritis
Innovating orthopedic materials and devices for fracture repair and joint replacement
Exploring therapeutic approaches to prevent metastatic bone cancer
Creating pro-anabolic agents to enhance bone health in conditions like X-linked hypophosphatemia

I also manage a pre-clinical bio-testing facility that supports research and development for both the government and private sectors.
Beyond my academic roles, I serve as Director of the Bone Health Foundation, a charitable organisation dedicated to promoting research, education, and public awareness of bone and musculoskeletal health. In this capacity, I help shape the Foundation’s strategic direction, including seed funding important and innovative bone health research from across Australia, supporting community outreach and fundraising efforts, and advocating for evidence-based approaches to preventing osteoporosis, fractures, and other skeletal diseases.

New projects:

11/6/2025: TekCyte and Central Adelaide Local Health Network Partnership: Preventing implant-acquired infection of orthopaedic implants using a novel anti-infective coating

1/1/2023: NHMRC Ideas project: Protecting vitamin D levels to prevent chemotherapy-induced gastrointestinal mucositis

1/1/2022: NHMRC Ideas project: Establishing a New Bone Pathologic Pathway and Solving Problems of Diagnosis in Chronic Orthopaedic Infections

1/6/2021: Bone Health Foundation: Assessment of an engineered, anti-microbial nanostructured implant surface for the treatment of diabetic fractures

16/11/2020: MTPConnect, BioMedTech Horizons, MRFF: Nano-optimised surface to prevent orthopaedic and dental implant infections.

1/1/19: NHMRC Project: Identifying novel vitamin D therapies to treat Chronic Kidney Disease-Mineral Bone Disorders 

1/10/18: M. Cochran OA project: Identify novel therapeutic targets to prevent the initiation and progression of Osteoarthritis 

1/6/18: Bone Health Foundation/Royal Adelaide Hospital: Identifying the dietary calcium level to prevent bone disease in overweight people.

12/3/18: Innovative Manufacturing Cooperative Research Centre: Development of novel anti-microbial nanosurfaces for orthopaedic medical devices.

Date Position Institution name
2015 - ongoing Honorary Secretary Australian and New New Zealand Bone and Mineral Society

Year Citation
2026 Thianhlun, P. C. K., Sylvester, C. L., Sawyer, R. K., Wardill, H. R., Stringer, A. M., & Anderson, P. H. (2026). Targeted deletion of Cyp24a1 in the intestine reduces mucosal injury and preserves epithelial proliferation after 5-fluorouracil treatment. Journal of Steroid Biochemistry and Molecular Biology, 255(106857), 10 pages.
DOI
2025 Hindes, M. T., McElligott, A. M., Best, O. G., Ward, M. P., Selemidis, S., Miles, M. A., . . . Brooks, D. A. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters, 611(217441), 217441-1-217441-18.
DOI Scopus7 WoS7 Europe PMC3
2025 Fleet, J. C., Watkins, N. M., Anderson, P. H., Jones, G., & Kaufmann, M. (2025). The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice. Journal of Steroid Biochemistry and Molecular Biology, 250(106735), 9 pages.
DOI Scopus1 WoS1 Europe PMC1
2024 Li, M., Bennett, M. K., Toubia, J., Pope, V. S., Tea, M. N., Tamang, S., . . . Pitson, S. M. (2024). An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma. British Journal of Haematology, 204(2), 566-570.
DOI Scopus1 WoS1 Europe PMC1
2023 Munem, F., Thianhlun, P. C. K., Anderson, P. H., & Stringer, A. M. (2023). Vitamin D is a potential treatment for the management of gastrointestinal mucositis. Current Opinion in Supportive and Palliative Care, 17(3), 247-252.
DOI Scopus8 WoS8 Europe PMC6
2023 Lee, Y. -R., Briggs, M. T., Kuliwaba, J. S., Jagiello, J., Anderson, P. H., & Hoffmann, P. (2023). Complex-Type <i>N</i>-Glycans Are Associated with Cartilage Degeneration within Different Loading Sites of the Tibial Plateau for Knee Osteoarthritis Patients. Journal of Proteome Research, 22(8), 2694-2702.
DOI Scopus4 WoS4 Europe PMC3
2023 Lee, Y. -R., Briggs, M. T., Kuliwaba, J. S., Jagiello, J., Anderson, P. H., & Hoffmann, P. (2023). High-Resolution <i>N</i>-Glycan MALDI Mass Spectrometry Imaging of Subchondral Bone Tissue Microarrays in Patients with Knee Osteoarthritis. Analytical Chemistry, 95(34), 12575-12992.
DOI Scopus3 WoS3 Europe PMC5
2023 Sung, J., Barratt, K. R., Pederson, S. M., Chenu, C., Reichert, I., Atkins, G. J., . . . Smitham, P. J. (2023). Unbiased gene expression analysis of the delayed fracture healing observed in Zucker diabetic fatty rats.. Bone & Joint Research, 12(10), 657-666.
DOI Scopus4 WoS4 Europe PMC4
2022 Lee, Y. -R., Briggs, M. T., Young, C., Condina, M. R., Kuliwaba, J. S., Anderson, P. H., & Hoffmann, P. (2022). Mass spectrometry imaging spatially identifies complex-type N-glycans as putative cartilage degradation markers in human knee osteoarthritis tissue. Analytical and Bioanalytical Chemistry, 414(26), 7597-7607.
DOI Scopus9 WoS9 Europe PMC7
2022 Visalakshan, R. M., Bright, R., Burzava, A. L. S., Barker, A. J., Simon, J., Ninan, N., . . . Vasilev, K. (2022). Antibacterial nanostructured surfaces modulate protein adsorption, inflammatory responses, and fibrous capsule formation. ACS Applied Materials and Interfaces, 15(1), 220-235.
DOI Scopus20 WoS18 Europe PMC10
2022 Alshabrawy, A. K., Cui, Y., Sylvester, C., Yang, D., Petito, E. S., Barratt, K. R., . . . Anderson, P. H. (2022). Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12(7), 1-14.
DOI Scopus7 WoS8 Europe PMC8
2022 Jones, C. F., Quarrington, R. D., Tsangari, H., Starczak, Y., Mulaibrahimovic, A., Burzava, A. L. S., . . . Anderson, P. H. (2022). A Novel Nanostructured Surface on Titanium Implants Increases Osseointegration in a Sheep Model. Clinical Orthopaedics &amp; Related Research, 480(11), 2232-2250.
DOI Scopus11 WoS10 Europe PMC6
2021 Lee, Y. R., Briggs, M. T., Kuliwaba, J. S., Anderson, P. H., Condina, M. R., & Hoffmann, P. (2021). Gelatin-coated indium tin oxide slides improve human cartilage-bone tissue adherence and N-glycan signal intensity for mass spectrometry imaging. Analytical and Bioanalytical Chemistry, 413(10), 2675-2682.
DOI Scopus14 WoS14 Europe PMC11
2021 Barratt, K. R., Sawyer, R. K., Atkins, G. J., St-Arnaud, R., & Anderson, P. H. (2021). Vitamin D supplementation improves bone mineralisation independent of dietary phosphate in male X-linked hypophosphatemic (Hyp) mice. Bone, 143(115767), 115767-1-115767-9.
DOI Scopus9 WoS7 Europe PMC7
2021 Starczak, Y., Reinke, D. C., Barratt, K. R., Russell, P. K., Clarke, M. V., Davey, R. A., . . . Anderson, P. H. (2021). Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice. Journal of Steroid Biochemistry and Molecular Biology, 210(105857), 1-7.
DOI Scopus12 WoS10 Europe PMC8
2021 Alshabrawy, A. K., Bergamin, A., Sharma, D. K., Hickey, S. M., Brooks, D. A., O'Loughlin, P., . . . Anderson, P. H. (2021). LC-MS/MS analysis of vitamin D₃ metabolites in human serum using a salting-out based liquid-liquid extraction and DAPTAD derivatization. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1173(122654), 122654-1-122654-9.
DOI Scopus14 WoS13 Europe PMC9
2021 Zhang, Y. -L., Liu, L., Peymanfar, Y., Anderson, P., & Xian, C. J. (2021). Roles of microRNAs in osteogenesis or adipogenesis differentiation of bone marrow stromal progenitor cells. International Journal of Molecular Sciences, 22(13), 18 pages.
DOI Scopus28 WoS34 Europe PMC24
2021 Sharma, D. K., Anderson, P. H., Morris, H. A., & Clifton, P. M. (2021). Acute CTX-1 Suppression With Milk Calcium or Calcium Carbonate is Independent of Visceral Fat in A Randomized Crossover Study in Lean and Overweight Postmenopausal Women.. J Nutr, 152(4), 1006-1014.
DOI Scopus4 WoS4 Europe PMC2
2021 Huang, A., Binmahfouz, L., Hancock, D. P., Anderson, P. H., Ward, D. T., & Conigrave, A. D. (2021). Calcium-Sensing Receptors Control CYP27B1-Luciferase Expression: Transcriptional and Posttranscriptional Mechanisms. Journal of the Endocrine Society, 5(9), 18 pages.
DOI Scopus5 WoS6 Europe PMC7
2020 Wilson, R. L., Phillips, J. A., Bianco-Miotto, T., McAninch, D., Goh, Z., Anderson, P. H., & Roberts, C. T. (2020). Reduced dietary calcium and vitamin D results in preterm birth and altered placental morphogenesis in mice during pregnancy. Reproductive Sciences, 27(6), 1330-1339.
DOI Scopus21 WoS16 Europe PMC13
2020 Sylvester, C. L., Anderson, P. H., & Stringer, A. M. (2020). New therapeutic strategies for combatting gastrointestinal toxicity. Current Opinion in Supportive and Palliative Care, 14(2), 142-152.
DOI Scopus5 WoS4 Europe PMC3
2020 Sharma, D. K., Anderson, P. H., Morris, H. A., & Clifton, P. M. (2020). Visceral Fat Is a Negative Determinant of Bone Health in Obese Postmenopausal Women.. Int J Environ Res Public Health, 17(11), 1-12.
DOI Scopus31 WoS28 Europe PMC27
2020 Hng, C. H., Camp, E., Anderson, P., Breen, J., Zannettino, A., & Gronthos, S. (2020). HOPX regulates bone marrow-derived mesenchymal stromal cell fate determination via suppression of adipogenic gene pathways. Scientific Reports, 10(1), 1-14.
DOI Scopus16 WoS16 Europe PMC13
2020 Lee, Y. R., Briggs, M. T., Condina, M. R., Puddy, H., Anderson, P. H., Hoffmann, P., & Kuliwaba, J. S. (2020). Mass spectrometry imaging as a potential tool to investigate human osteoarthritis at the tissue level. International Journal of Molecular Sciences, 21(17), 6414-1-6414-13.
DOI Scopus14 WoS12 Europe PMC11
2019 Sheng, L., Turner, A. G., Barratt, K., Kremer, R., Morris, H. A., Callen, D. F., . . . Tarulli, G. A. (2019). Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D. Journal of Steroid Biochemistry and Molecular Biology, 189, 240-247.
DOI Scopus21 WoS17 Europe PMC18
2019 Hassanshahi, M., Anderson, P. H., Sylvester, C. L., & Stringer, A. M. (2019). Highlight article: Current evidence for vitamin D in intestinal function and disease. Experimental Biology and Medicine, 244(12), 1040-1052.
DOI Scopus13 WoS12 Europe PMC6
2019 Sharma, D. K., Sawyer, R. K., Robertson, T. S., Stamenkov, R., Solomon, L. B., Atkins, G. J., . . . Anderson, P. H. (2019). Elevated Serum 25-Hydroxyvitamin D Levels Are Associated with Improved Bone Formation and Micro-Structural Measures in Elderly Hip Fracture Patients.. Journal of clinical medicine, 8(11), 10 pages.
DOI Scopus16 WoS12 Europe PMC10
2018 Solomon, L., Kitchen, D., Anderson, P., Yang, D., Starczak, Y., Kogawa, M., . . . Atkins, G. (2018). Time dependent loss of trabecular bone in human tibial plateau fractures. Journal of Orthopaedic Research, 36(11), 2865-2875.
DOI Scopus3 WoS3 Europe PMC3
2018 Wilson, R., Leviton, A., Leemaqz, S., Anderson, P., Grieger, J., Grzeskowiak, L., . . . Roberts, C. (2018). Vitamin D levels in an Australian and New Zealand cohort and the association with pregnancy outcome. BMC Pregnancy and Childbirth, 18(1), 1-10.
DOI Scopus32 WoS27 Europe PMC23
2018 Yang, D., Anderson, P., Wijenayaka, A., Barratt, K., Triliana, R., Stapledon, C., . . . Atkins, G. (2018). Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D₃ on osteoblast differentiation. Journal of Steroid Biochemistry and Molecular Biology, 177, 83-90.
DOI Scopus17 WoS13 Europe PMC11
2018 Kogawa, M., Khalid, K., Wijenayaka, A., Ormsby, R., Evdokiou, A., Anderson, P., . . . Atkins, G. (2018). Recombinant sclerostin antagonises effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size. American Journal of Physiology - Cell Physiology, 314(1), 53-61.
DOI Scopus29 WoS27 Europe PMC22
2018 Starczak, Y., Reinke, D., Barratt, K., Ryan, J., St-Arnaud, R., Morris, H., . . . Anderson, P. (2018). Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss. Journal of Steroid Biochemistry and Molecular Biology, 177, 77-82.
DOI Scopus22 WoS17 Europe PMC13
2017 Reinke, D., Starczak, Y., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2017). Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 177, 96-102.
DOI Scopus3 WoS2 Europe PMC1
2017 Anderson, P. H. (2017). Vitamin D activity and metabolism in bone. Current osteoporosis reports, 15(5), 443-449.
DOI Scopus87 WoS80 Europe PMC64
2016 Triliana, R., Lam, N., Sawyer, R., Atkins, G., Morris, H., & Anderson, P. (2016). Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model. Journal of Steroid Biochemistry and Molecular Biology, 164, 331-336.
DOI Scopus12 WoS9 Europe PMC9
2016 Sheng, L., Anderson, P., Turner, A., Pishas, K., Dhatrak, D., Gill, P., . . . Callen, D. (2016). Identification of vitamin D₃ target genes in human breast cancer tissue. Journal of Steroid Biochemistry and Molecular Biology, 164, 90-97.
DOI Scopus32 WoS26 Europe PMC24
2016 Reinke, D., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2016). Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 353-360.
DOI Scopus12 WoS8 Europe PMC8
2016 Wijenayaka, A., Prideaux, M., Yang, D., Morris, H., Findlay, D., Anderson, P., & Atkins, G. (2016). Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 164, 369-373.
DOI Scopus14 WoS12 Europe PMC13
2016 Ryan, J., Starczak, Y., Tsangari, H., Sawyer, R., Davey, R., Atkins, G., . . . Anderson, P. (2016). Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 361-368.
DOI Scopus14 WoS12 Europe PMC11
2016 Yang, D., Anderson, P., Turner, A., Morris, H., & Atkins, G. (2016). Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D₃ on the mature osteoblast cell line MLO-A5. Journal of Steroid Biochemistry and Molecular Biology, 164, 374-378.
DOI Scopus6 WoS5 Europe PMC5
2016 Klassen, K., Kimlin, M., Fairley, C., Emery, S., Anderson, P., & Ebeling, P. (2016). Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV. Osteoporosis International, 27(5), 1737-1745.
DOI Scopus10 WoS8 Europe PMC8
2015 Ryan, J., Anderson, P., & Morris, H. (2015). Pleiotropic activities of vitamin D receptors - adequate activation for multiple health outcomes. Clinical Biochemist Reviews, 36(2), 53-61.
Scopus55 Europe PMC43
2015 Russell, P., Clarke, M., Cheong, K., Anderson, P., Morris, H., Wiren, K., . . . Davey, R. (2015). Androgen receptor action in osteoblasts in male mice is dependent on their stage of maturation. Journal of Bone and Mineral Research, 30(5), 809-823.
DOI Scopus22 WoS19 Europe PMC16
2015 Buckberry, S., Spronk, F., Wilson, R. L., Laurence, J. A., Bianco-Miotto, T., Leemaqz, S., . . . Roberts, C. T. (2015). The effect of Vdr gene ablation on global gene expression in the mouse placenta. Genomics Data, 6, 72-73.
DOI Scopus2 WoS2 Europe PMC2
2015 Yang, D., Turner, A., Wijenayaka, A., Anderson, P., Morris, H., & Atkins, G. (2015). 1,25-Dihydroxyvitamin D₃ and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5. Molecular and Cellular Endocrinology, 412(C), 140-147.
DOI Scopus23 WoS20 Europe PMC19
2015 Wilson, R. L., Buckberry, S., Spronk, F., Laurence, J. A., Leemaqz, S., O'Leary, S., . . . Roberts, C. T. (2015). Vitamin D receptor gene ablation in the conceptus has limited effects on placental morphology, function and pregnancy outcome. PLoS One, 10(6), e0131287-1-e0131287-17.
DOI Scopus24 WoS19 Europe PMC18
2015 Wijenayaka, A., Yang, D., Prideaux, M., Ito, N., Kogawa, M., Anderson, P., . . . Atkins, G. (2015). 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Molecular and Cellular Endocrinology, 413(C), 157-167.
DOI Scopus44 WoS37 Europe PMC32
2015 Clarke, M., Russell, P., Findlay, D., Sastra, S., Anderson, P., Skinner, J., . . . Davey, R. (2015). A role for the Calcitonin respetor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis. Endocrinology, 156(9), 3203-3214.
DOI Scopus48 WoS35 Europe PMC27
2015 Yang, D., Atkins, G. J., Turner, A. G., Anderson, P. H., & Morris, H. A. (2015). Erratum: Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures (Journal of Steroid Biochemistry and Molecular Biology (2013) 136 166-170). Journal of Steroid Biochemistry and Molecular Biology, 147, 125.
DOI
2014 Yip, K., Kolesnikoff, N., Yu, C., Hauschild, N., Taing, H., Biggs, L., . . . Grimbaldeston, M. (2014). Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation. Journal of Allergy and Clinical Immunology, 133(5), 1356-1379.
DOI Scopus101 WoS88 Europe PMC78
2014 Lam, N., Triliana, R., Sawyer, R., Atkins, G., Morris, H., O'Loughlin, P., & Anderson, P. (2014). Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. Journal of Steroid Biochemistry and Molecular Biology, 144(PART A), 128-131.
DOI Scopus34 WoS27 Europe PMC25
2014 Turner, A., Hanrath, M., Morris, H., Atkins, G., & Anderson, P. (2014). The local production of 1,25(OH)₂D₃ promotes osteoblast and osteocyte maturation. The Journal of Steroid Biochemistry and Molecular Biology, 144(Part A), 114-118.
DOI Scopus49 WoS40 Europe PMC36
2014 Ormsby, R., Findlay, D., Kogawa, M., Anderson, P., Morris, H., & Atkins, G. (2014). Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling. The Journal of Steroid Biochemistry and Molecular Biology, 144(Part A), 110-113.
DOI Scopus27 WoS25 Europe PMC18
2014 Lee, A., Sawyer, R., Moore, A., Morris, H., O'Loughlin, P., & Anderson, P. (2014). Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume. The Journal of Steroid Biochemistry and Molecular Biology, 144(Part A), 159-162.
DOI Scopus17 WoS14 Europe PMC11
2013 Ryan, J., Reinke, D., Kogawa, M., Turner, A., Atkins, G., Anderson, P., & Morris, H. (2013). Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Current Drug Targets, 14(14), 1683-1688.
DOI Scopus21 WoS22 Europe PMC17
2013 Kogawa, M., Wijenayaka, A., Ormsby, R., Thomas, G., Anderson, P., Bonewald, L., . . . Atkins, G. (2013). Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Journal of Bone and Mineral Research, 28(12), 2436-2448.
DOI Scopus142 WoS128 Europe PMC110
2013 Kogawa, M., Hisatake, K., Atkins, G., Findlay, D., Enoki, Y., Sato, T., . . . Matsumoto, M. (2013). The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-kB ligand (RANKL)-induced Osteoclast differentiation. Journal of Biological Chemistry, 288(43), 31299-31312.
DOI Scopus21 WoS21 Europe PMC15
2013 Ito, N., Findlay, D., Anderson, P., Bonewald, L., & Atkins, G. (2013). Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D₃ (1,25D) on osteocyte like cells. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 183-186.
DOI Scopus52 WoS47 Europe PMC48
2013 Yang, D., Atkins, G., Turner, A., Anderson, P., & Morris, H. (2013). Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 166-170.
DOI Scopus28 WoS24 Europe PMC18
2013 Kogawa, M., Findlay, D., Anderson, P., & Atkins, G. (2013). Modulation of osteoclastic migration by metabolism of 25(OH)-vitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 59-61.
DOI Scopus16 WoS13 Europe PMC9
2013 Anderson, P., Lam, N., Turner, A., Davey, R., Kogawa, M., Atkins, G., & Morris, H. (2013). The pleiotropic effects of vitamin D in bone. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 190-194.
DOI Scopus56 WoS46 Europe PMC38
2013 Ryan, J. W., Anderson, P. H., Turner, A. G., & Morris, H. A. (2013). Vitamin D activities and metabolic bone disease. Clinica Chimica Acta, 425, 148-152.
DOI Scopus37 WoS33 Europe PMC28
2013 O'Loughlin, P., Lee, A., Anderson, P. H., Steck, R., Forwood, M., Sawyer, R., & Morris, H. A. (2013). Vitamin D levels of >85 nmol/l in the presence of adequate dietary Ca minimise bone turnover and improve bone strength. Bone Abstracts, 1, 1.
DOI
2012 Morris, H., Turner, A., & Anderson, P. (2012). Vitamin-D regulation of bone mineralization and remodelling during growth. Frontiers in Bioscience, E4(2), 677-689.
DOI Scopus21 Europe PMC15
2012 Davey, R., Clarke, M., Sastra, S., Skinner, J., Chiang, C., Anderson, P., & Zajac, J. (2012). Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Transgenic Research, 21(4), 885-893.
DOI Scopus88 WoS88 Europe PMC86
2012 Anderson, P., Turner, A., & Morris, H. (2012). Vitamin D actions to regulate calcium and skeletal homeostasis. Clinical Biochemistry, 45(12), 880-886.
DOI Scopus62 WoS55 Europe PMC48
2012 Pyragius, C., Derrick Roberts, A., Ding, X., Zarrinkalam, K., McIntyre, C., Anderson, P., . . . Byers, S. (2012). Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII. Molecular Genetics and Metabolism, 106(2), 202-213.
DOI Scopus29 WoS29 Europe PMC27
2012 Turner, A., Anderson, P., & Morris, H. (2012). Vitamin D and bone health. Scandinavian Journal of Clinical & Laboratory Investigation, 72(0), 65-72.
DOI Scopus70 WoS59 Europe PMC41
2012 Moghaddami, M., Mayrhofer, G., Anderson, P., Morris, H., Van der Hoek, M., & Cleland, L. (2012). Efficacy and mechanisms of action of vitamin D in experimental polyarthritis. Immunology and Cell Biology, 90(2), 168-177.
DOI Scopus18 WoS18 Europe PMC16
2011 Yu, C., Fedoric, B., Anderson, P., Lopez, A., & Grimbaldeston, M. (2011). Vitamin D₃ signalling to mast cells: A new regulatory axis. International Journal of Biochemistry & Cell Biology, 43(1), 41-46.
DOI Scopus31 Europe PMC16
2011 Anderson, P., Atkins, G., Turner, A., Kogawa, M., Findlay, D., & Morris, H. (2011). Vitamin D metabolism within bone cells: Effects on bone structure and strength. Molecular and Cellular Endocrinology, 347(1-2 Sp Is), 42-47.
DOI Scopus56 WoS54 Europe PMC34
2011 Yu, C., Fedoric, B., Anderson, P. H., Lopez, A. F., & Grimbaldeston, M. A. (2011). Vitamin D<sub>3</sub> signalling to mast cells: A new regulatory axis. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 43(1), 41-46.
DOI WoS24
2011 Morris, H. A., & Anderson, P. H. (2011). Vitamin D metabolism and biological activities. Molecular and cellular endocrinology, 347(1), 1-2.
DOI Scopus4 WoS5 Europe PMC5
2010 Morris, H. A., & Anderson, P. H. (2010). Autocrine and paracrine actions of vitamin D. Clinical biochemist reviews, 31(4), 129-138.
Europe PMC86
2010 Anderson, P. H., Lida, S., Tyson, J. H. T., Turner, A. G., & Morris, H. A. (2010). Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts. Journal of steroid biochemistry and molecular biology, 121(1/2), 71-75.
DOI Scopus38 WoS31 Europe PMC24
2010 Kogawa, M., Findlay, D., Anderson, P., Ormsby, R., Vincent, C., Morris, H., & Atkins, G. (2010). Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorption. Endocrinology, 151(10), 4613-4625.
DOI Scopus131 WoS111 Europe PMC88
2010 Sharma, R., Iachini, D., Neilsen, P., Kaplan, J., Michalakas, J., Anderson, P., . . . Callen, D. (2010). Systematic characterisation of the rat and human CYP24A1 promoter. Molecular and Cellular Endocrinology, 325(1-2), 46-53.
DOI Scopus21 WoS14 Europe PMC12
2010 Lee, A., Anderson, P., Sawyer, R., Moore, A., Forwood, M., Steck, R., . . . O'Loughlin, P. (2010). Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2), 284-287.
DOI Scopus13 WoS12 Europe PMC11
2010 Kogawa, M., Anderson, P., Findlay, D., Morris, H., & Atkins, G. (2010). The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2 Sp Iss), 277-280.
DOI Scopus69 WoS55 Europe PMC42
2010 Anderson, P., Lee, A., Anderson, S., Sawyer, R., O'Loughlin, P., & Morris, H. (2010). The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2), 288-292.
DOI Scopus37 WoS32 Europe PMC21
2010 Morris, H. A., O'Loughlin, P. D., & Anderson, P. H. (2010). Experimental evidence for the effects of calcium and vitamin D on bone: a review. Nutrients, 2(9), 1026-1035.
DOI Scopus32 WoS29 Europe PMC24
2009 Turner, A., Dwivedi, P., Anderson, P., May, B., & Morris, H. (2009). Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells. Molecular and Cellular Endocrinology, 311(1-2), 55-61.
DOI Scopus8 WoS8 Europe PMC8
2009 Chiang, C., Chiu, M., Moore, A., Anderson, P., Ghasem-Zadeh, A., McManus, J., . . . Davey, R. (2009). Mineralization and Bone Resorption Are Regulated by the Androgen Receptor in Male Mice. Journal of Bone and Mineral Research, 24(4), 621-631.
DOI Scopus98 WoS91 Europe PMC82
2009 Anderson, P., Sawyer, R., Moore, A., Atkins, G., O'Loughlin, P., & Morris, H. (2009). Osteocyte cell density is reduced during vitamin D depletion and predicts osteoclast surface and bone mineral volume. Bone: cell molecular biology; pathophysiology; treatment, 44(Supplement 1), S131.
DOI
2008 Anderson, P., & Atkins, G. (2008). The skeleton as an intracrine organ for vitamin D metabolism. Molecular Aspects of Medicine, 29(6), 397-406.
DOI Scopus84 WoS81 Europe PMC61
2008 Anderson, P., Sawyer, R., Moore, A., May, B., O'Loughlin, P., & Morris, H. (2008). Vitamin D Depletion Induces RANKL-Mediated Osteoclastogenesis and Bone Loss in a Rodent Model. Journal of Bone and Mineral Research, 23(11), 1789-1797.
DOI Scopus84 WoS74 Europe PMC60
2008 Davey, R., Turner, A., McManus, J., Chiu, W., Tjahyono, F., Moore, A., . . . Zajac, J. (2008). Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. Journal of Bone and Mineral Research, 23(8), 1182-1193.
DOI Scopus90 WoS76 Europe PMC54
2008 Anderson, P., Hendrix, I., Sawyer, R., Zarrinkalam, R., Manavis, J., Sarvestani, G., . . . Morris, H. (2008). Co-expression of CYP27B1 enzyme with the 1.5 kb CYP27B1 promoter-luciferase transgene in the mouse. Molecular and Cellular Endocrinology, 285(1-2), 1-9.
DOI Scopus43 WoS30 Europe PMC20
2007 Tan, J., Dwivedi, P., Anderson, P., Nutchey, B., O'Loughlin, P., Morris, H., . . . Hii, C. (2007). Antineoplastic agents target the 25-hydroxyvitamin D-3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity. Molecular Cancer Therapeutics, 6(12 Part 1), 3131-3138.
DOI Scopus10 WoS8 Europe PMC5
2007 Atkins, G., Anderson, P., Findlay, D., Welldon, K., Vincent, C., Zannettino, A., . . . Morris, H. (2007). Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃. Bone, 40(6), 1517-1528.
DOI Scopus228 WoS201 Europe PMC173
2007 Dwivedi, P., Anderson, P., Tilley, W., May, B., & Morris, H. (2007). Role of oncoprotein Growth Factor Independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): A comparative analysis in human prostate cancer and kidney cells. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 742-746.
DOI Scopus8 WoS6 Europe PMC6
2007 Anderson, P., Atkins, G., Findlay, D., O'Loughlin, P., Welldon, K., Vincent, C., & Morris, H. (2007). RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)₂D₃ synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 601-605.
DOI Scopus43 WoS35 Europe PMC28
2007 Anderson, P., Sawyer, A., May, B., O'Loughlin, P., & Morris, H. (2007). 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 592-595.
DOI Scopus38 WoS29 Europe PMC27
2005 Parashar, S., Anderson, P., Takagi, S., Tan, E., & David, D. (2005). Modification of technique in midface distraction. Plastic and Reconstructive Surgery, 116(3), 926.
DOI
2005 Hendrix, I., Anderson, P., Omdahl, J., May, B., & Morris, H. (2005). Response of the 5' -flanking region of the human 25-hydroxyvitamin D 1a-hydroxylase gene to physiological stimuli using a transgenic mouse model. Journal of Molecular Endocrinology, 34(1), 237-245.
DOI Scopus25 WoS19 Europe PMC17
2005 Dwivedi, P., Anderson, P., Omdahl, J., Grimes, H., Morris, H., & May, B. (2005). Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP271B1) gene expression in human prostate cancer cells. Endocrine-Related Cancer, 12(2), 351-365.
DOI Scopus33 WoS31 Europe PMC29
2005 Anderson, P., O'Loughlin, P., May, B., & Morris, H. (2005). Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone, 36(4), 654-662.
DOI Scopus75 WoS62 Europe PMC56
2004 Hendrix, I., Anderson, P., May, B., & Morris, H. (2004). Regulation of gene expression by the CYP27B1 promoter - study of a transgenic mouse model. Journal of Steroid Biochemistry and Molecular Biology, 89-90(May 2004), 139-142.
DOI Scopus24 WoS22 Europe PMC15
2004 Anderson, P., O'Loughlin, P., May, B., & Morris, H. (2004). Determinants of circulating 1,25-dihydroxyvitamin D₃ levels: the role of renal synthesis and catabolism of vitamin D. Journal of Steroid Biochemistry and Molecular Biology, 89-90(May 2004), 111-113.
DOI Scopus41 WoS39 Europe PMC30
2003 Anderson, P., May, B., & Morris, H. (2003). Vitamin D metabolism: new concepts and clinical implications. Clinical Biochemist Reviews, 24(1), 13-26.
Europe PMC59
2003 Anderson, P., O'Loughlin, P., May, B., & Morris, H. (2003). Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. Journal of Molecular Endocrinology, 31(1), 123-132.
DOI Scopus64 WoS52 Europe PMC46
2001 Anderson, P. H., Iida, S., Moore, A. J., May, B. K., Cochran, M., & Morris, H. A. (2001). Bone cell regulation of vitamin D metabolism. BONE, 28(5), S245-S246.
WoS1
2001 Anderson, P. H., Iida, S., Moore, A. J., Cochran, M., O'Loughlin, P. D., May, B. K., & Morris, H. A. (2001). Bone Cyp27b1 mRNA is regulated by dietary calcium and not vitamin D status.. JOURNAL OF BONE AND MINERAL RESEARCH, 16, S313.
WoS2

Year Citation
2023 Anderson, P. H. (2023). Vitamin D activity in osteoblasts and osteocytes. In Feldman and Pike S Vitamin D Volume One Biochemistry Physiology and Diagnostics (Vol. 1, 5th ed., pp. 409-418). UK: Elsevier.
DOI
2018 Anderson, P., Atkins, G., Morris, H., & Findlay, D. (2018). Vitamin D Activities in Osteocytes. In D. Feldman, J. W. Pike, R. Bouillon, E. Giovannucci, D. Goltzman, & M. Hewison (Eds.), Vitamin D: Fourth Edition (Vol. 1, 4th ed., pp. 319-327). London, United Kingdom: Academic Press.
DOI Scopus1
2014 Morris, H., Anderson, P., & Nordin, B. (2014). Vitamin D: Activities for bone health. In H. Morris, P. Anderson, & B. Nordin (Eds.), The Physiological Basis of Metabolic Bone Disease (pp. 167-186). United States: Taylor and Francis.
Scopus1
2014 Morris, H., Anderson, P., & Nordin, B. (2014). Preface. In H. Morris, P. Anderson, & B. Nordic (Eds.), The Physiological Basis of Metabolic Bone Disease (pp. vii). USA: CRC Press.
2014 Morris, H. A., Anderson, P. H., & Nordin, B. E. C. (2014). Preface - Physiological basis of metabolic bone disease. In Source details - Title: Physiological basis of metabolic bone disease (pp. 1). US: CRC Press (Taylor and Francis).
2011 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2011). Target Genes: Bone proteins. In Vitamin D Two Volume Set (Vol. 1-2, pp. 411-424).
DOI
2011 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2011). Target genes: Bone proteins. In D. Feldman, J. Pike, & J. Adams (Eds.), Vitamin D (Vol. 1, 3rd ed., pp. 411-424). Elsevier.
DOI Scopus26
2004 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2004). Target genes: bone proteins. In D. Feldman, J. Pike, & F. Glorieux (Eds.), Vitamin D, 2nd. ed (Vol. 1, 2nd ed., pp. 711-720). San Diego, California: Elsevier Academic Press.
DOI Scopus4
2004 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2004). Target Genes: Bone Proteins. In Vitamin D Second Edition (pp. 711-720).
DOI

Year Citation
2019 Sylvester, C. L., Anderson, P. H., & Stringer, A. M. (2019). Inhibition of vitamin D catabolism and its effects on chemotherapy-induced gastrointestinal mucositis. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 15 (pp. 62). WILEY.
2018 Sharma, D. K., Stamenkov, R., Robertson, T., Stapledon, C. J. M., Atkins, G. J., Solomon, L. B., . . . Morris, H. A. (2018). SERUM 25-HYDROXYVITAMIN D AND ITS METABOLISM IN BONE TISSUE IS ASSOCIATED WITH IMPROVED BONE QUALITY IN ELDERLY HIP PATIENTS. In OSTEOPOROSIS INTERNATIONAL Vol. 29 (pp. S271). Krakow, POLAND: SPRINGER LONDON LTD.
2011 Turner, A. G., O'loughlin, P. D., Kogawa, M., Atkins, G. J., Anderson, P. H., & Morris, H. A. (2011). INCREASED BONE VOLUME IN THE BONE-SPECIFIC CYP27B1 TRANSGENIC MOUSE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S590-S591). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
WoS5
2011 Kogawa, M., Findlay, D. M., Anderson, P. H., Morris, H. A., & Atkins, G. J. (2011). 25(OH)-VITAMIN D3 ACTS DIRECTLY ON OSTEOCLASTS TO REDUCE RESORPTION: WHAT IS THE MECHANISM?. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S586). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Yang, D., Atkins, G. J., Anderson, P. H., Welldon, K. J., & Morris, H. A. (2011). THE ROLE OF VITAMIN D IN THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS IN VITRO. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S592). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2009 O'Loughlin, P. D., Tyson, J., Anderson, P. H., & Morris, H. A. (2009). Oestradiol protects 1.25 dihydroxyvitamin D from catabolism by CYP24 in intestinal cells. In BONE Vol. 44 (pp. S62). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Morris, H. A., Moore, A. J., Moore, R. J., Need, A. G., O'Loughlin, P. D., Nordin, C., & Anderson, P. H. (2009). Dietary calcium and oestradiol protect osteocyte density and bone structure against the effects of ovariectomy. In BONE Vol. 44 (pp. S61). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI WoS1
2009 Kogawa, M., Findlay, D. M., Anderson, P. H., Vincent, C., & Atkins, G. J. (2009). The metabolism of 25(OH)-vitamin D<sub>3</sub> by osteoclast precursors regulates the differentiation and function of osteoclasts. In BONE Vol. 44 (pp. S60-S61). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Danks, J. A., Scanlon, D. B., Daly, N., Craik, D. J., Sneddon, W. B., & Richardson, S. J. (2009). Trabecular and cortical bone changes due to long term vitamin D deficiency in senescent animals. In BONE Vol. 44 (pp. S168-S169). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2008 Anderson, P. H., Atkins, G. J., Sawyer, R. K., Findlay, D. M., O'Loughlin, P. D., & Morris, H. A. (2008). The Requirement of the Bone for Vitamin D for 1,25(OH)<sub>2</sub>D<sub>3</sub> Synthesis and Bone Mineralisation.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S429). Montreal, CANADA: WILEY-BLACKWELL.
WoS1
2007 Anderson, P. H., Sawye, R. K., More, A. J., Muliabrahimovic, A., May, B. K., O'Loughlin, P. D., & Morris, H. A. (2007). Sub-optimal 25(OH)D<sub>3</sub> levels causes increased osteoclastogenesis and bone loss. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 22 (pp. S464). Honolulu, HI: AMER SOC BONE & MINERAL RES.
2004 Atkins, G. J., Anderson, P. H., Welldon, K., Zannettino, A. C. W., Morris, H. A., & Findlay, D. M. (2004). Vitamin D metabolism in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 19 (pp. S204). Seattle, WA: AMER SOC BONE & MINERAL RES.
2004 Atkins, G., Anderson, P., Welldon, K., Zannettino, A., Morris, H., & Findlay, D. (2004). Vitamin D metabolism in human osteoblasts. In Journal of Bone and Mineral Research Vol. 19 (pp. SA-587). Seattle, Washington: American Society for Bone and Mineral Research.
2003 Atkins, G. J., Anderson, P. H., Morris, H. A., Zannettino, A. C. W., Kostakis, P., & Findlay, D. M. (2003). The expression of 25-hydroxyvitamin D 24-hydroxylase and 25-hydroxyvitamin D 1 alpha-hydroxylase in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 18 (pp. S409). MINNEAPOLIS, MINNESOTA: AMER SOC BONE & MINERAL RES.

Year Citation
2017 Sheng, L., Turner, A. G., Tarulli, G. A., Barratt, K., Kremer, R., Morris, H. A., . . . Anderson, P. H. (2017). Conditional inactivation of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) in the mouse mammary epithelium alters mammary gland development. Poster session presented at the meeting of CANCER RESEARCH. San Antonio, TX: AMER ASSOC CANCER RESEARCH.
DOI WoS1
2012 Lee, A. M., Anderson, P. H., Steck, R., Forwood, M., Sawyer, R. K., Morris, H. A., & O'Loughlin, P. D. (2012). VITAMIN D LEVELS OF GREATER THAN 85 NMOL/L IN THE PRESENCE OF ADEQUATE DIETARY CA MINIMISE BONE TURNOVER AND IMPROVE BONE STRENGTH. Poster session presented at the meeting of OSTEOPOROSIS INTERNATIONAL. Bordeaux, FRANCE: SPRINGER LONDON LTD.
2011 Morris, H. A., Turner, A. G., Sawyer, R. K., O'Loughlin, P. D., & Anderson, P. H. (2011). Increased trabecular bone volume in the bone-specific CYP27B1 transgenic mouse. Poster session presented at the meeting of Bone. US: Elsevier.
DOI WoS1
2010 Roberts, C. T., Thompson, S. D., Furness, D. F., Lee, S. Y., Anderson, P. H., & Morris, H. (2010). INTERACTIONS BETWEEN VITAMIN D RELATED GENES AND MATERNAL CIRCULATING 25OH VITAMIN D3 IN PREGNANCY COMPLICATIONS IN AN AUSTRALIAN POPULATION. Poster session presented at the meeting of PLACENTA. Santiago, CHILE: W B SAUNDERS CO LTD.
WoS1
2003 Atkins, G., Anderson, P., Morris, H., Zannettino, A., Kostakis, P., & Findlay, D. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts. Poster session presented at the meeting of Journal of Bone Mineral Research. Minnesota, USA.
2003 Anderson, P., Atkins, G., Morris, H., Kostakis, P., Findlay, D., & Zannettino, A. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts.. Poster session presented at the meeting of Calcified Tissue International. Rome, Italy: Springer.

Year Citation
2022 Anderson, P. (2022). CN2022104643298, Novel inhibitor compounds.

  • Anti-biofilm coatings for implantable devices, Health Services Charitable Gifts Board, 26/11/2025 - 31/03/2027

  • Therapeutic Targeting of Vitamin D Catabolism in Chronic Kidney Disease, NHMRC - Project Grant, 01/01/2019 - 31/12/2022

  • IMCRC - An antimicrobial nanosurface for orthopaedic implants, Innovative Manufacturing CRC Limited, 01/02/2018 - 30/06/2022

  • Does enhanced vitamin D activity in bone heal the skeleton in disorders of FGF23 excess?, NHMRC - Project Grant, 01/01/2017 - 31/12/2019

  • Osteocyte regulation of bone mass, NHMRC - Project Grant, 01/01/2016 - 31/12/2019

  • Vitamin D cream absorption study, VitaSalts AG, 05/10/2016 - 30/04/2017

Date Role Research Topic Program Degree Type Student Load Student Name
2014 - 2017 Co-Supervisor Vitamin D Signaling Pathway and Breast Cancer Doctor of Philosophy Doctorate Full Time Mr Lei Sheng
2012 - 2020 Co-Supervisor The Role of Vitamin D Autocrine Activity and Signalling in Osteoclast Formation and Activity Doctor of Philosophy Doctorate Full Time Daniel Christopher Reinke
2011 - 2015 Co-Supervisor The Effect of Vitamin D on Placental Development and Pregnancy Success Doctor of Philosophy Doctorate Full Time Dr Jessica Phillips
2011 - 2017 Co-Supervisor The Role of Calcium in Mature Osteoblasts Vitamin D Receptor (VDR)-Mediated Activities to Modulate Skeletal Structures and Mineral Content Doctor of Philosophy Doctorate Full Time Mrs Rahma Triliana
2010 - 2011 Co-Supervisor The Role of Dietary Vitamin D and Calcium in Determining Bone Health and Strength Doctor of Philosophy Doctorate Full Time Miss Ming Lee
2010 - 2013 Co-Supervisor The Role of Vitamin D Receptor in Osteoblasts and Bone Mineralisation Doctor of Philosophy Doctorate Full Time Miss Nga Lam

Connect With Me

External Profiles

Other Links